Advertisement

Topics

Atreca Raises $35M to Advance Novel Cancer Immunotherapies

13:50 EDT 17 Aug 2017 | Drug Discovery Development

Additional participation included new investor Cormorant Asset Management, based in Boston, as well as other new and existing investors.
Contributed Author: 
Atreca
Topics: 

Original Article: Atreca Raises $35M to Advance Novel Cancer Immunotherapies

NEXT ARTICLE

More From BioPortfolio on "Atreca Raises $35M to Advance Novel Cancer Immunotherapies"

Advertisement
Quick Search
Advertisement
Advertisement